Multifactorial intervention in Type 2 diabetes: the promise of incretin-based therapies.
about
GLP-1 and cardioprotection: from bench to bedsideAlogliptin as an initial therapy in patients with newly diagnosed, drug naïve type 2 diabetes: a randomized, control trialDPP-4 inhibitors and lipids: systematic review and meta-analysis.HD047703, a New Promising Anti-Diabetic Drug Candidate: In Vivo Preclinical Studies.Circulating glucagon-like peptide-1 increases in response to short-term overfeeding in men.Cardiovascular disease and glycemic control in type 2 diabetes: now that the dust is settling from large clinical trials.In vivo efficacy of HD0471953: a novel GPR119 agonist for the treatment of type 2 diabetes mellitus.GLP-1: benefits beyond pancreas.Response: The Effect of DPP-4 Inhibitors on Metabolic Parameters in Patients with Type 2 Diabetes (Diabetes Metab J 2014;38:211-9).Comparisons of the efficacy of glucose control, lipid profile, and β-cell function between DPP-4 inhibitors and AGI treatment in type 2 diabetes patients: a meta-analysis.Long-term treatment with the dipeptidyl peptidase-4 inhibitor saxagliptin in patients with type 2 diabetes mellitus and renal impairment: a randomised controlled 52-week efficacy and safety study.
P2860
Q27024984-28590F24-1A72-4C71-B9FD-3616FB7FA4D0Q28257600-662E6E64-5DF6-4FDC-99CD-06A7F51D17CFQ34116689-E4D03C3A-7489-4E50-B924-1CB34243568AQ34360545-FDB1E9C5-54B0-4EE2-AC68-446E45B2754BQ36766657-00F55790-CA76-4AF0-A9B6-213BCB57A0BBQ37023878-4F8C4AC6-8B1C-4353-A493-93F42C485E95Q37412882-C313D754-7431-44BD-BF7D-11FBB08482B6Q38238288-92C866CC-B74C-4BFC-8A92-AD3FCE3423DCQ42872676-44C7B437-1EA8-4225-8682-340E41CB7482Q51301791-E68F60F4-BBFC-458F-B4D2-E5E7E6613D49Q51367101-6A73BBDC-E6A6-4695-94A7-8CCF64435358
P2860
Multifactorial intervention in Type 2 diabetes: the promise of incretin-based therapies.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 13 January 2011
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Multifactorial intervention in Type 2 diabetes: the promise of incretin-based therapies.
@en
Multifactorial intervention in Type 2 diabetes: the promise of incretin-based therapies.
@nl
type
label
Multifactorial intervention in Type 2 diabetes: the promise of incretin-based therapies.
@en
Multifactorial intervention in Type 2 diabetes: the promise of incretin-based therapies.
@nl
prefLabel
Multifactorial intervention in Type 2 diabetes: the promise of incretin-based therapies.
@en
Multifactorial intervention in Type 2 diabetes: the promise of incretin-based therapies.
@nl
P2093
P2860
P356
P1476
Multifactorial intervention in Type 2 diabetes: the promise of incretin-based therapies.
@en
P2093
A Leonardini
A Natalicchio
F Giorgino
P2860
P2888
P356
10.1007/BF03346698
P577
2011-01-13T00:00:00Z